Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients.
Gu S, Dusza S, Quigley E, Haliasos H, Markova A, Marchetti M, Moy AP, Dang C, Modi S, Lake D, Noor S, Lacouture ME. Gu S, et al. Among authors: markova a. Breast Cancer Res Treat. 2024 Jan;203(2):271-280. doi: 10.1007/s10549-023-07143-3. Epub 2023 Oct 13. Breast Cancer Res Treat. 2024. PMID: 37833451 Free PMC article.
Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer Patients.
Gu S, Dusza S, Quigley E, Haliasos H, Markova A, Marchetti M, Moy A, Dang C, Modi S, Lake D, Noor S, Lacouture M. Gu S, et al. Among authors: markova a. Res Sq [Preprint]. 2023 Apr 28:rs.3.rs-2679676. doi: 10.21203/rs.3.rs-2679676/v1. Res Sq. 2023. Update in: Breast Cancer Res Treat. 2024 Jan;203(2):271-280. doi: 10.1007/s10549-023-07143-3 PMID: 37163123 Free PMC article. Updated. Preprint.
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
Chen ST, Semenov YR, Alloo A, Bach DQ, Betof Warner A, Bougrine A, Burton L, Cappelli LC, Castells M, Cohen J, Dewan AK, Fadden R, Guggina L, Hegde A, Huang V, Johnson DB, Kaffenberger B, Kroshinsky D, Kwatra S, Kwong B, Lacouture ME, Larocca C, Leventhal J, Markova A, McDunn J, Mooradian MJ, Naidoo J, Choi J, Nambudiri V, Nelson CA, Patel AB, Pimkina J, Rine J, Rubin KM, Sauder M, Shaigany S, Shariff A, Sullivan RJ, Zubiri L, Reynolds KL, LeBoeuf NR. Chen ST, et al. Among authors: markova a. J Immunother Cancer. 2024 Apr 10;12(4):e007675. doi: 10.1136/jitc-2023-007675. J Immunother Cancer. 2024. PMID: 38599660 Free PMC article.
Oral minoxidil for late alopecia in cancer survivors.
Kuo AM, Reingold RE, Ketosugbo KF, Pan A, Kraehenbuehl L, Dusza S, Gajria D, Lake DE, Bromberg JF, Traina TA, Fornier MN, Gucalp A, D'Alessandro BM, Rotemberg V, Dauscher M, Shapiro J, Goldfarb SB, Markova A, Lacouture ME. Kuo AM, et al. Among authors: markova a. Breast Cancer Res Treat. 2024 Dec;208(3):491-499. doi: 10.1007/s10549-024-07440-5. Epub 2024 Aug 4. Breast Cancer Res Treat. 2024. PMID: 39097564
Omalizumab for Treatment of Anti-GD2 Antibody-related Urticaria.
Glincher R, Lentini-Rivera A, Andre Jones L, D'Andrea L, Durney C, Kasper C, Lin Y, Shrager L, Markova A, Lacouture M, Modak S. Glincher R, et al. Among authors: markova a. J Pediatr Hematol Oncol. 2024 Oct 1;46(7):e531-e533. doi: 10.1097/MPH.0000000000002939. Epub 2024 Aug 22. J Pediatr Hematol Oncol. 2024. PMID: 39177945
Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series.
Adames A, O'Brien DR, Kelly AR, Saltz LB, Garcia-Aguilar J, Zinovoy M, Williams V, Wu A, Reyngold M, Hajj C, Crane C, Cercek A, Smith JJ, Markova A, Cuaron J, McCann P, Romesser PB. Adames A, et al. Among authors: markova a. Int J Colorectal Dis. 2024 May 23;39(1):75. doi: 10.1007/s00384-024-04647-2. Int J Colorectal Dis. 2024. PMID: 38780794 Free PMC article.
207 results